intestinal microbiota metabolism of l-carnitine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial to TMAO: Cell Metabolism Frontiers | Gut macrobiotic and
Frontiers Gut macrobiotic and its metabolic pathways modulate cardiovascular disease High l Carnitine Ingestion Impairs Liver Function by Disordering Gut Bacteria Composition in Mice Journal of Agricultural and Food Chemistry Carnitine Metabolite of the month biocrates life sciences gmbh Chlorogenic acid inhibits trimethylamine N oxide formation and remodels intestinal microbiota to alleviate liver dysfunction in high l carnitine feeding mice Food & Function (RSC Publishing) Elucidation of an anaerobic pathway for metabolism of l carnitinederived butyrobetaine to trimethylamine in human gut bacteria PNAS
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10


